Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emmanouil Fokas

Showing results (71-80 of 158) with videos related to

Pageof 16
Sort By:
Journal of the National Cancer Institute|October 20, 2011
Delta-like ligand 4-notch blockade and tumor radiation responseStanley K Liu, Saif A S Bham, Emmanouil Fokas, et al.
Oncology Reports|December 22, 2007
Increased expression of EphA2 correlates with adverse outcome in primary and recurrent glioblastoma multiforme patientsLin-Fang Wang, Emmanouil Fokas, Michael Bieker, et al.
International Journal of Radiation Oncology, Biology, Physics|July 16, 2010
Atlas-based semiautomatic target volume definition (CTV) for head-and-neck tumorsGerd Strassmann, Soulimane Abdellaoui, Detlef Richter, et al.
Clinical and Translational Radiation Oncology|April 22, 2022
ACO/ARO/AIO-21 - Capecitabine-based chemoradiotherapy in combination with the IL-1 receptor antagonist anakinra for rectal cancer Patients: A phase I trial of the German rectal cancer study groupMaximilian Fleischmann, Markus Diefenhardt, Adele M Nicolas, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|January 7, 2026
Shaping the future of radiation oncology education: results of a nationwide student survey from GermanyHendrik Dapper, Michael Oertel, Hilke Vorwerk, et al.
Oral Oncology|November 7, 2024
Can we safely de-escalate HPV<sup>+</sup> oropharyngeal cancers? - A review of current practices and novel approachesJanis Morgenthaler, Maike Trommer, Richard Khor, et al.
Frontiers in Oncology|February 9, 2019
Merkel Cell Polyoma Viral Load and Intratumoral CD8+ Lymphocyte Infiltration Predict Overall Survival in Patients With Merkel Cell CarcinomaJens von der Grün, Ria Winkelmann, Markus Meissner, et al.
Cancers|November 26, 2022
Prognostic Impact of Caspase-8, CDK9 and Phospho-CDK9 (Thr 186) Expression in Patients with Uterine Cervical Cancer Treated with Definitive Chemoradiation and BrachytherapyMaximilian Fleischmann, Ranadip Mandal, Izabela Kostova, et al.
BMC Cancer|December 23, 2009
Decreased mitochondrial DNA content in blood samples of patients with stage I breast cancerPeng Xia, Han-Xiang An, Cheng-Xue Dang, et al.
Radiation Oncology (London, England)|March 29, 2012
NVP-BEZ235 and NVP-BGT226, dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitors, enhance tumor and endothelial cell radiosensitivityEmmanouil Fokas, Michio Yoshimura, Remko Prevo, et al.
Pageof 16

Showing results (71-80 of 158) with videos related to

Sort By:
Pageof 16
Journal of the National Cancer Institute|October 20, 2011
Delta-like ligand 4-notch blockade and tumor radiation responseStanley K Liu, Saif A S Bham, Emmanouil Fokas, et al.
Oncology Reports|December 22, 2007
Increased expression of EphA2 correlates with adverse outcome in primary and recurrent glioblastoma multiforme patientsLin-Fang Wang, Emmanouil Fokas, Michael Bieker, et al.
International Journal of Radiation Oncology, Biology, Physics|July 16, 2010
Atlas-based semiautomatic target volume definition (CTV) for head-and-neck tumorsGerd Strassmann, Soulimane Abdellaoui, Detlef Richter, et al.
Clinical and Translational Radiation Oncology|April 22, 2022
ACO/ARO/AIO-21 - Capecitabine-based chemoradiotherapy in combination with the IL-1 receptor antagonist anakinra for rectal cancer Patients: A phase I trial of the German rectal cancer study groupMaximilian Fleischmann, Markus Diefenhardt, Adele M Nicolas, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|January 7, 2026
Shaping the future of radiation oncology education: results of a nationwide student survey from GermanyHendrik Dapper, Michael Oertel, Hilke Vorwerk, et al.
Oral Oncology|November 7, 2024
Can we safely de-escalate HPV<sup>+</sup> oropharyngeal cancers? - A review of current practices and novel approachesJanis Morgenthaler, Maike Trommer, Richard Khor, et al.
Frontiers in Oncology|February 9, 2019
Merkel Cell Polyoma Viral Load and Intratumoral CD8+ Lymphocyte Infiltration Predict Overall Survival in Patients With Merkel Cell CarcinomaJens von der Grün, Ria Winkelmann, Markus Meissner, et al.
Cancers|November 26, 2022
Prognostic Impact of Caspase-8, CDK9 and Phospho-CDK9 (Thr 186) Expression in Patients with Uterine Cervical Cancer Treated with Definitive Chemoradiation and BrachytherapyMaximilian Fleischmann, Ranadip Mandal, Izabela Kostova, et al.
BMC Cancer|December 23, 2009
Decreased mitochondrial DNA content in blood samples of patients with stage I breast cancerPeng Xia, Han-Xiang An, Cheng-Xue Dang, et al.
Radiation Oncology (London, England)|March 29, 2012
NVP-BEZ235 and NVP-BGT226, dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitors, enhance tumor and endothelial cell radiosensitivityEmmanouil Fokas, Michio Yoshimura, Remko Prevo, et al.
Pageof 16